Not available
Quote | Altimmune Inc. (NASDAQ:ALT)
Last: | $7.30 |
---|---|
Change Percent: | -3.06% |
Open: | $7.41 |
Close: | $7.30 |
High: | $7.63 |
Low: | $7.19 |
Volume: | 2,009,482 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
News | Altimmune Inc. (NASDAQ:ALT)
2024-05-03 10:28:54 ET More on Amgen Amgen, Inc. (AMGN) Q1 2024 Earnings Call Transcript Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Biggest stock movers today: WOW, AAPL, SQ, and more Amge...
GAITHERSBURG, Md., May 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 and will provide a business update. Altimmune management w...
Message Board Posts | Altimmune Inc. (NASDAQ:ALT)
Subject | By | Source | When |
---|---|---|---|
Keep shorting until you get blown out over | trendzone | investorshub | 04/19/2023 2:13:12 PM |
Im not touching this till it revisits the | nate2028 | investorshub | 03/31/2023 6:57:53 PM |
whytestocks: $ALT News Article - Altimmune Appoints Former GSK Executive Catherine Angell Sohn, Phar | whytestocks | investorshangout | 03/27/2023 8:15:49 PM |
Interesting board! Like a ghost town! I bought | Jnk | investorshub | 03/27/2023 7:11:45 PM |
whytestocks: $ALT News Article - Wall Street Absolutely Loved This Biotech Stock. But It Just Crashe | whytestocks | investorshangout | 03/22/2023 12:00:45 PM |
News, Short Squeeze, Breakout and More Instantly...
GAITHERSBURG, Md., May 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 and will provide a business update. Altimmune management w...
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present on behalf of the Company at the following two upcoming conferences: ...
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily ...